C

Cooper Companies Inc
LSE:0I3I

Watchlist Manager
Cooper Companies Inc
LSE:0I3I
Watchlist
Price: 94.41 USD 3.01% Market Closed
Market Cap: 468.2B USD
Have any thoughts about
Cooper Companies Inc?
Write Note

Cooper Companies Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cooper Companies Inc
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
C
Cooper Companies Inc
BMV:COO
Net Income (Common)
$392.3m
CAGR 3-Years
-49%
CAGR 5-Years
-3%
CAGR 10-Years
4%
Haemonetics Corp
NYSE:HAE
Net Income (Common)
$123.8m
CAGR 3-Years
58%
CAGR 5-Years
13%
CAGR 10-Years
15%
ICU Medical Inc
NASDAQ:ICUI
Net Income (Common)
-$111m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Net Income (Common)
$441.6m
CAGR 3-Years
-16%
CAGR 5-Years
1%
CAGR 10-Years
12%
Lantheus Holdings Inc
NASDAQ:LNTH
Net Income (Common)
$427.6m
CAGR 3-Years
N/A
CAGR 5-Years
65%
CAGR 10-Years
N/A
Merit Medical Systems Inc
NASDAQ:MMSI
Net Income (Common)
$120m
CAGR 3-Years
40%
CAGR 5-Years
45%
CAGR 10-Years
19%
No Stocks Found

Cooper Companies Inc
Glance View

Market Cap
468.2B USD
Industry
Health Care

In the world of healthcare innovation, Cooper Companies Inc. etched its name as a significant player, specializing in creating products that enhance lives, particularly in the fields of vision care and women’s health. Established in 1958, Cooper Companies evolved to become a holding company operating through its two primary business units: CooperVision and CooperSurgical. CooperVision is renowned globally for its expertise in contact lenses, providing a diversified range of lenses to correct myopia, hyperopia, astigmatism, and presbyopia. By leveraging cutting-edge technology and a deep understanding of wearer needs, CooperVision caters to a wide spectrum of users, from daily disposables to specialty lenses, thus driving consistent revenue through the consumable nature of its products. CooperSurgical, on the other hand, focuses on solutions for women’s health, offering a gamut of medical instruments, devices, and diagnostics. This unit extends Cooper Companies' footprint into the realms of fertility products, contraception, and obstetrics. By addressing key segments of the women’s health market, CooperSurgical supports clinical needs across a woman’s lifespan. Revenue opportunities here arise from both its durable medical equipment and consumable products, which ensure a stream of repeat business as healthcare providers replenish their supplies. Together, these divisions enable Cooper Companies to not only secure a robust market position but also continuously explore new areas for growth and expansion within the broader healthcare industry.

0I3I Intrinsic Value
696.33 USD
Undervaluation 86%
Intrinsic Value
Price
C

See Also

What is Cooper Companies Inc's Net Income (Common)?
Net Income (Common)
392.3m USD

Based on the financial report for Oct 31, 2024, Cooper Companies Inc's Net Income (Common) amounts to 392.3m USD.

What is Cooper Companies Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
4%

Over the last year, the Net Income (Common) growth was 33%. The average annual Net Income (Common) growth rates for Cooper Companies Inc have been -49% over the past three years , -3% over the past five years , and 4% over the past ten years .

Back to Top